IsoPlexis Corporation (ISO) IPO Opens Modestly Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
IsoPlexis Announces Pricing of Initial Public Offering
October 7, 2021 6:13 PM EDTBRANFORD, Conn., Oct. 7, 2021 /PRNewswire/ --Â IsoPlexis Corporation ("IsoPlexis"), a leader in functional single-cell proteomics, today announced the pricing of its initial public offering of 8,333,000Â shares of common stock at a public offering price of $15.00 per share. All of the shares of common stock are being offered by IsoPlexis. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by IsoPlexis, are expected to be $125.0 million, excluding any exercise of the underwriters' option to purchase additional shares. IsoPlexis' common stock is expected to begin trading on The Nasdaq Global Select Market... More
